Sort
64,565 grants matching “drug discovery”
Engineered Nanoformulation for Immune-modulation in Cancer
$564,843Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · CA
Core 4: Animal Breeding (UAB) and Exposure Core (MRIGLOBAL)
$564,801Mohammad Athar · University Of Alabama At Birmingham · U54 · FY2019 · ES
Synthesis Directed Toward Therapeutic Agents
$564,797Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R01 · FY2013 · GM
The Impact of Human Gene Knockouts in Type 2 Diabetes and Related Traits
$564,758Michael Boehnke · University Of Michigan At Ann Arbor · R01 · FY2013 · DK
Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosis
$564,741Steven Mark Rowe · University Of Alabama At Birmingham · U01 · FY2024 · HL
Transposon-Mediated Gene Therapy for Fanconi Anemia
$564,735R Scott McIvor · Discovery Genomics, Inc. · R44 · FY2007 · HL
Clinical - Protocol Specific Res. Support
$564,720Edward J Benz · Dana-Farber Cancer Inst · P30 · FY2007 · CA
A Novel Gyrase Inhibitor for the Treatment of Drug-susceptible and Multidrug-resistant Mycobacterium tuberculosis Infections
$564,718Michael J Pucci · Spero Therapeutics, Inc. · R44 · FY2017 · AI
Development Of P2Y Receptor Ligands
$564,699Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Mechanisms of Extinction Memory Enhancement for Cocaine Addiction Treatment
$564,695Kathleen M. Kantak · Boston University (Charles River Campus) · R01 · FY2017 · DA
Candidate Medications for Cannabis Addiction: FAAH Inhibitors
$564,664Jack Bergman · Mclean Hospital · R01 · FY2012 · DA
Heteroresistance Interdisciplinary Research Unit (Project 2)
$564,570David S Weiss · Emory University · U19 · FY2021 · AI
Pharmacology of Lifespan Extension
$564,544Gordon J. Lithgow · Buck Institute For Research On Aging · R01 · FY2015 · AG
Lamina Propria Antigen Acquisition Pathways and Outcomes
$564,530Rodney D Newberry · Washington University · U01 · FY2012 · AI
Defining the Pathogenesis and Prognosis of Human Acute Interstitial Nephritis
$564,483Lloyd G Cantley · Yale University · R01 · FY2020 · DK
An Integrative Radiogenomic Approach to Design Genetically-Informed Image Biomarker for Characterizing COPD
$564,472Kayhan Batmanghelich · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL
An Integrative Radiogenomic Approach to Design Genetically-Informed Image Biomarker for Characterizing COPD
$564,472Kayhan Batmanghelich · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · HL
An Integrative Radiogenomic Approach to Design Genetically-Informed Image Biomarker for Characterizing COPD
$564,472Kayhan Batmanghelich · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · HL
Project 4: A Discovery-Level Functional Proteomics/Metabolomics Platform for Resolving the Heterogeneity of GBM Tumors and Identifying Effective Therapy Combinations
$564,460James R. Heath · California Institute Of Technology · U54 · FY2016 · CA
Regenbase: A Searchable Database to Organize Regeneration Knowledge via Ontologie
$564,445Vance P Lemmon · University Of Miami School Of Medicine · R01 · FY2014 · NS
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects
$564,433Alexander A Soukas · Massachusetts General Hospital · R01 · FY2022 · AG
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects
$564,432Alexander A Soukas · Massachusetts General Hospital · R01 · FY2021 · AG
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects
$564,432Alexander A Soukas · Massachusetts General Hospital · R01 · FY2020 · AG
Transcription termination and gene regulation by Rho: Integrative analysis
$564,325Evgeny Nudler · New York University School Of Medicine · R01 · FY2021 · GM
Mechanisms controlling the efficiency of hemostatic vitamin K-dependent protein activation
$564,308Kathleen Lucile Berkner · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · HL